chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Fibromyalgia, Headache, Heart rate, Heart rate decreased
Clinical narrative: 5+ days of chest tightness; Low heart rate (47-51 BPM); Fatigue/Exhaustion; Headache; Nausea; Vomiting; Fibromayalgia symptoms; Diarrhea; Cold feet/hands; Muscle shaking; Confusion; Abdomen discomfort; Joint pain; This is a spontaneous report from a contactable consumer (patient). A 26-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: EW0161) via an unspecified route of administration, administered in Arm Left on 23Apr2021 19:15 at the age of (26-years-old) as a dose 2, single for covid-19 immunization. Medical history included sjogren's syndrome, Hashimoto's, fibromyalgia, asthma, endometriosis, Penicillin allergy. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Concomitant medication included hydroxychloroquine taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient did not diagnose with covid-19. Since the vaccination patient was not diagnosed with covid-19. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: ER8730) via an unspecified route of administration, administered on an unspecified date in mar2021 at 07:00 PM as a single dose for covid-19 immunisation. It was reported that on 24Apr2021 13:00 the patient experienced 5+ days of chest tightness, low heart rate (47-51 BPM), fatigue/exhaustion, headache, nausea, vomiting, Fibromyalgia symptoms, diarrhoea, cold feet/hands, muscle shaking, confusion, abdomen discomfort & joint pain. On 24Apr2021 the patient underwent lab tests and procedures which included heart rate which includes low heart rate (47-51 bpm), on 27Apr2021 Nasal Swab test: negative, PCR test: negative, Rapid Test: Negative Nasal Swab. On 29Apr2021 COVID-19 BY NAAT PCR, TMA: negative. The patient was recovering from the events.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Peripheral coldness, SARS-CoV-2 test, Tremor, Vomiting
Clinical narrative: 5+ days of chest tightness; Low heart rate (47-51 BPM); Fatigue/Exhaustion; Headache; Nausea; Vomiting; Fibromayalgia symptoms; Diarrhea; Cold feet/hands; Muscle shaking; Confusion; Abdomen discomfort; Joint pain; This is a spontaneous report from a contactable consumer (patient). A 26-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: EW0161) via an unspecified route of administration, administered in Arm Left on 23Apr2021 19:15 at the age of (26-years-old) as a dose 2, single for covid-19 immunization. Medical history included sjogren's syndrome, Hashimoto's, fibromyalgia, asthma, endometriosis, Penicillin allergy. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Concomitant medication included hydroxychloroquine taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient did not diagnose with covid-19. Since the vaccination patient was not diagnosed with covid-19. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: ER8730) via an unspecified route of administration, administered on an unspecified date in mar2021 at 07:00 PM as a single dose for covid-19 immunisation. It was reported that on 24Apr2021 13:00 the patient experienced 5+ days of chest tightness, low heart rate (47-51 BPM), fatigue/exhaustion, headache, nausea, vomiting, Fibromyalgia symptoms, diarrhoea, cold feet/hands, muscle shaking, confusion, abdomen discomfort & joint pain. On 24Apr2021 the patient underwent lab tests and procedures which included heart rate which includes low heart rate (47-51 bpm), on 27Apr2021 Nasal Swab test: negative, PCR test: negative, Rapid Test: Negative Nasal Swab. On 29Apr2021 COVID-19 BY NAAT PCR, TMA: negative. The patient was recovering from the events.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Swelling, Tenderness
Clinical narrative: Experiencing aching pain on injection site side of body( right); tender and moveable lump on collarbone; tender and moveable lump on collarbone; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 29Apr2021 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021, the patient experienced aching pain on injection site side of body (right) and at night after the vaccine, the patient noticed a tender and moveable lump on collarbone. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events aching pain on injection site side of body(right), tender and moveable lump on collarbone were not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Metamorphopsia
Clinical narrative: Distorted vision in right eye; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 29Apr2021 at 13:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 11:00, the patient experienced distorted vision in right eye. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event distorted vision in right eye was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Patient contracted COVID four months after receiving PFE/BNT vaccine; Patient contracted COVID four months after receiving PFE/BNT vaccine; This is a spontaneous report from a contactable consumer via agency. An adult male patient of unspecified age received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in Dec2020 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no concomitant medications. Prior to vaccination the patient had not been diagnosed with COVID-19. It was reported the patient contracted COVID four months after receiving BNT162B2. It was reported the patient tested positive for COVID post-vaccination. It was unknown if treatment was received. The clinical outcomes of the events were unknown.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Headache, Hypoaesthesia oral, Lymph node pain
Clinical narrative: Itchy palms; Numbness in mouth; Tooth pain; Headache; Excessive thirst; Nausea; Joint pain throughout body; Lymph glands hurt; Low grade temp 99.1 within 2 hours of shot; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW9175) via an unspecified route of administration in the arm left on 29Apr2021 at 15:30(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2 (controlled with medication), undetermined autoimmune, mild hypothyroidism and mild hypertension. The patient has taken unspecified concomitant medications. The patient was known allergic to sulfa drugs, latex and cinnamon. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 15:30, the patient experienced itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date, the patient underwent body temperature test and the result was 99.1(units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Pruritus, Pyrexia, Thirst
Clinical narrative: Itchy palms; Numbness in mouth; Tooth pain; Headache; Excessive thirst; Nausea; Joint pain throughout body; Lymph glands hurt; Low grade temp 99.1 within 2 hours of shot; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW9175) via an unspecified route of administration in the arm left on 29Apr2021 at 15:30(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2 (controlled with medication), undetermined autoimmune, mild hypothyroidism and mild hypertension. The patient has taken unspecified concomitant medications. The patient was known allergic to sulfa drugs, latex and cinnamon. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 15:30, the patient experienced itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date, the patient underwent body temperature test and the result was 99.1(units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: Itchy palms; Numbness in mouth; Tooth pain; Headache; Excessive thirst; Nausea; Joint pain throughout body; Lymph glands hurt; Low grade temp 99.1 within 2 hours of shot; Malaise; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW9175) via an unspecified route of administration in the arm left on 29Apr2021 at 15:30(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2 (controlled with medication), undetermined autoimmune, mild hypothyroidism and mild hypertension. The patient has taken unspecified concomitant medications. The patient was known allergic to sulfa drugs, latex and cinnamon. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 15:30, the patient experienced itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date, the patient underwent body temperature test and the result was 99.1(units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy palms, numbness in mouth, tooth pain, headache, excessive thirst, nausea, joint pain throughout body, lymph glands hurt, low grade temp of 99.1 within 2 hours of shot and malaise was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Pruritus, Rash, Skin sensitisation
Clinical narrative: Shingles; rash on right side of face, above right eye brow spreading to the back of the ear to the bottom of the jaw line; Itching; Sensitivity; This is a spontaneous report from a non-contactable healthcare professional. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) on 09Apr2021 (at the age of 37-years-old) as a dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. On Apr2021, 1.5 days after the vaccination, the patient experienced rash on right side of face, above right eye brow spreading to the back of the ear to the bottom of the jaw line, some sensitivity and itching, shingles. Provider (Cancer Center) thought it might be shingles, another (Express Care) told patient to take BENADRYl and PEPCID. Therapeutic measures included cetirizine hydrochloride (ZYRTEC) as a result of events. The patient planned to use this if reaction occurred again. The clinical outcome of the events rash on right side of face, above right eye brow spreading to the back of the ear to the bottom of the jaw line, some sensitivity and itching, shingles was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Nausea, Pain, Pyrexia
Clinical narrative: dizziness; body aches; Nausea; chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 29Apr2021 at 09:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included diverticulitis and hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN) and levothyroxine sodium (SYNTHROID) both for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0158) via an unspecified route of administration in left arm on 08Apr2021 at 09:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 21:00 the patient experienced nausea, dizziness, fever, chills and body aches which were lasting 15 hours or so. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of nausea, dizziness, fever, chills and body aches was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected. .
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Crepitations, Fatigue, Joint swelling, Muscle spasms
Clinical narrative: My knees, wrists, ankles and feet have started popping and cracking every day.; Lower leg muscles cramp, feet tingle slightly towards the end of the day.; Joints are very sore and swollen by the end of the day. I am now having to use creams and take asprin or tylenol to calm them down and get to sleep.; My legs and feet used to get tired before however, this is extreme after shot and my joints are a new thing that was never an issue.; Lower leg muscles cramp, feet tingle slightly towards the end of the day.; Joints are very sore and swollen by the end of the day. I am now having to use creams and take asprin or tylenol to calm them down and get to sleep.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 08:30 (at the age of 52-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 08:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included overweight. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination were reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 03Apr2021 at 16:00, the patients knees, wrists, ankles and feet had started popping and cracking every day. The patient also experienced lower leg muscles cramp, feet tingled slightly towards the end of the day. Joints were very sore and swollen by the end of the day. The patient had to start having to use creams and take asprin or tylenol to calm them down and get to sleep. The patients legs and feet used to get tired before however, this was extreme after shot and his joints were a new thing that was never an issue. The patient had not been able to find help on the subject of what should be done. Therapeutic measures were taken as a result of joints were very sore and swollen by the end of the day and included treatment with asprin or tylenol. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events knees, wrists, ankles and feet had started popping and cracking every day; lower leg muscles cramp, feet tingled slightly towards the end of the day; joints were very sore and swollen by the end of the day; legs and feet used to get tired before however, this was extreme after shot and his joints were a new thing that was never an issue was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: My knees, wrists, ankles and feet have started popping and cracking every day.; Lower leg muscles cramp, feet tingle slightly towards the end of the day.; Joints are very sore and swollen by the end of the day. I am now having to use creams and take asprin or tylenol to calm them down and get to sleep.; My legs and feet used to get tired before however, this is extreme after shot and my joints are a new thing that was never an issue.; Lower leg muscles cramp, feet tingle slightly towards the end of the day.; Joints are very sore and swollen by the end of the day. I am now having to use creams and take asprin or tylenol to calm them down and get to sleep.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 08:30 (at the age of 52-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 08:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included overweight. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination were reported as not available. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 03Apr2021 at 16:00, the patients knees, wrists, ankles and feet had started popping and cracking every day. The patient also experienced lower leg muscles cramp, feet tingled slightly towards the end of the day. Joints were very sore and swollen by the end of the day. The patient had to start having to use creams and take asprin or tylenol to calm them down and get to sleep. The patients legs and feet used to get tired before however, this was extreme after shot and his joints were a new thing that was never an issue. The patient had not been able to find help on the subject of what should be done. Therapeutic measures were taken as a result of joints were very sore and swollen by the end of the day and included treatment with asprin or tylenol. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events knees, wrists, ankles and feet had started popping and cracking every day; lower leg muscles cramp, feet tingled slightly towards the end of the day; joints were very sore and swollen by the end of the day; legs and feet used to get tired before however, this was extreme after shot and his joints were a new thing that was never an issue was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Oral discomfort, Throat irritation, Tongue discomfort
Clinical narrative: About two weeks after the second shot my tongue, roof of my mouth and throat started burning. Some days are better than others but the burning has not gone away,; About two weeks after the second shot my tongue, roof of my mouth and throat started burning. Some days are better than others but the burning has not gone away,; About two weeks after the second shot my tongue, roof of my mouth and throat started burning. Some days are better than others but the burning has not gone away,; This is a spontaneous report from a contactable consumer, the patient. A 81-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6203) via an unspecified route of administration in the left arm on 28Feb2021 at 11:00 (at the age of 81-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism (reported as Thyroid hypo), cholesterol, ocular hypertension, and urinary incontinence. The patient previously took codeine (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy (reported as Codeine over sensitive). The patient had received other medication (unspecified) within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El9261) via an unspecified route of administration in the left arm on 06Feb2021 at 12:00 (at the age of 81-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Mar2021 at 12:15, about two weeks after the second shot the patients tongue, roof of her mouth and throat started burning. Some days were better than others but the burning had not gone away. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events about two weeks after the second shot the patients tongue, roof of mouth and throat started burning; some days were better than others but the burning had not gone away, was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypoaesthesia, Musculoskeletal stiffness, Sleep disorder, Walking disability
Clinical narrative: I feel terrible today. "I have 3 fingers on each hand will not bend  and there is some numbness/Fingers are stiffening up; can't bed them; both hands; I feel terrible today/It is scaring her.; I am disabled and I can't walk; I just don't want to go to sleep tonight and not wake up; her fingers are stiffening up; she can't bend them they get stuck; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown, at the age of 73 years), dose 1 via an unspecified route of administration on 29Apr2021 as dose 1, single for covid-19 immunisation. The medical history and concomitant medications were not reported. The patient reported, she received her 1st Pfizer vaccine dose yesterday. She felt terrible today. She had 3 fingers on each hand would not bend and there was some numbness. These symptoms started a couple of hours after the vaccine dose. States she was disabled and can't walk. She just don't want to go to sleep tonight and not wake up. Says her fingers are stiffening up; she can't bend them they get stuck. States they get stuck like as if she was pointing. It is happening on bother her hands. States she has no idea what it is. It is scaring her. All the events occurred on 29Apr2021. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: High heart rate; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of BNT162B2 (BNT162B2, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller stated she received the first dose of the Pfizer Covid 19 vaccine and she was experiencing now a high heart rate. She was asking to continue with the second dose or not. The patient underwent lab tests and procedures which included heart rate was high (unit not provided). The outcome of event was unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: left hand, left leg numbness; This is a spontaneous report from a contactable consumer or other non hcp reported for patient. A 33-years-old male patient received bnt162b2 (BNT162B2PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on 21Apr2021 as dose 1, single for COVID-19 immunisation. The medical history and concomitant medications of the patient were not reported. The patient experienced left hand, left leg numbness on an unspecified date. The reporter asked if should see HCP or Emergency. The outcome of the event was reported as unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 53-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 as a single dose for COVID-19 immunisation. On 28Apr2021,16 days after the second dose of vaccination, the patient experienced shingles for the first time. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event included treatment with antivirals. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was not recovered at the time of the report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Muscle tightness
Clinical narrative: Tightness; Muscle Pain in the injection site of the right arm; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the right arm on 30Apr2021 at 15:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, perimenopause, menorrhagia and COVID-19. The patient did not have any known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included biotin (MANUFACTURER UNKNOWN) and women's multivitamin (MANUFACTURER UNKNOWN); both started from an unknown date, for an unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. On 01May2021 at 00:00, the patient experienced tightness and muscle pain in the injection site of the right arm. Therapeutic measure was taken as a result of tightness and muscle pain in the injection site of the right arm which included treatment with ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, tightness and muscle pain in the injection site of the right arm was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anger, Emotional disorder, Feeling abnormal
Clinical narrative: felt a surge of anger; overwhelming feeling; became very emotional.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in left arm on 30Apr2021 at 14:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), pregabalin (LYRICA), naproxen (MANUFACTURER UNKNOWN), paracetamol (TYLENOL) and multi city (MANUFACTURER UNKNOWN)) all for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Apr2021 at 15:30, an hour and a half after receiving the vaccine the patient felt a surge of anger, overwhelming feeling and became very emotional. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt a surge of anger, overwhelming feeling and became very emotional was recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: Gout flare up in right knee and right big toe; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 25Apr2021 at 09:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included gout. It was reported the patient had gout-no flares for over ten years. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications within two weeks of vaccination The patient previously first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 02Apr2021 at 09:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 01:00, the patient experienced gout flare up in right knee and right big toe. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event Gout flare up in right knee and right big toe was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Palpitations, Tachycardia
Clinical narrative: Heart palpitations; Tachycardia at rest; Edema to bilateral lower extremities excluding feet; This is a spontaneous report from a contactable nurse, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 06Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included diabetes insipidus, pituitary tumor and hypothyroidism. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of the COVID-19 vaccination. The patient previously took influenza vaccine (MANUFACTURER UNKNOWN) and experienced allergy to the vaccine. The patient previously took hydromorphone hydrochloride (DILAUDID), sumatriptan (IMITREX), cefuroxime axetil (CEFTIN) and bupropion hydrochloride (WELLBUTRIN) and experienced drug allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021, the patient experienced heart palpitations, tachycardia at rest and edema to bilateral lower extremities excluding feet. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heart palpitations, tachycardia at rest and edema to bilateral lower extremities excluding feet was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Body temperature decreased, Dizziness, Fatigue, Hangover
Clinical narrative: Hangover feeling which continued the next day; I have had random fleeting dizzy feelings; Unusually tired; Had a dizzy spinning feeling when I looked up in my closet/ A week later had another spinning episode while shopping.; Almost lost my balance; Woke next day with headache/  Headache which lasted all day and night; Aches and pains; Sensitive skin; Low temperature; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history included Barrett's oesophagus, GERD, anxiety, hyperlipemia, osteoporosis, gastric ulcer, insomnia and irritable bowel syndrome (IBS). The patient previously took codeine (MANUFACTURER UNKNOWN), tramadol hydrochloride (ULTRAM), pseudoephedrine hydrochloride (SUDAFED) and zolpidem tartrate (AMBIEN) and experienced drug allergy. The patient received medications (unspecified) within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 02Mar2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 24Mar2021, the patient experienced headache, aches and pains, sensitive skin and low temperature. On 30Mar2021, a week later, the patient experienced a dizzy spinning feeling when she looked up in her closet and almost lost her balance which lasted maybe for 25-20 minutes. On 06Apr2021, a week later, the patient had another spinning episode while shopping, headache which lasted all day and night with a hangover feeling which continued the next day. Since then, she has had random fleeting dizzy feelings and unusually tired. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event almost lost her balance was recovered on 30Mar2021 and headache was recovered on an unknown date in Apr2021. The clinical outcome of the events aches and pains, sensitive skin, low temperature, dizzy spinning feeling when she looked up in her closet, spinning episode while shopping, with a hangover feeling, random fleeting dizzy feelings and unusually tired was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Sensitive skin, Vertigo
Clinical narrative: Hangover feeling which continued the next day; I have had random fleeting dizzy feelings; Unusually tired; Had a dizzy spinning feeling when I looked up in my closet/ A week later had another spinning episode while shopping.; Almost lost my balance; Woke next day with headache/  Headache which lasted all day and night; Aches and pains; Sensitive skin; Low temperature; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history included Barrett's oesophagus, GERD, anxiety, hyperlipemia, osteoporosis, gastric ulcer, insomnia and irritable bowel syndrome (IBS). The patient previously took codeine (MANUFACTURER UNKNOWN), tramadol hydrochloride (ULTRAM), pseudoephedrine hydrochloride (SUDAFED) and zolpidem tartrate (AMBIEN) and experienced drug allergy. The patient received medications (unspecified) within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 02Mar2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 24Mar2021, the patient experienced headache, aches and pains, sensitive skin and low temperature. On 30Mar2021, a week later, the patient experienced a dizzy spinning feeling when she looked up in her closet and almost lost her balance which lasted maybe for 25-20 minutes. On 06Apr2021, a week later, the patient had another spinning episode while shopping, headache which lasted all day and night with a hangover feeling which continued the next day. Since then, she has had random fleeting dizzy feelings and unusually tired. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event almost lost her balance was recovered on 30Mar2021 and headache was recovered on an unknown date in Apr2021. The clinical outcome of the events aches and pains, sensitive skin, low temperature, dizzy spinning feeling when she looked up in her closet, spinning episode while shopping, with a hangover feeling, random fleeting dizzy feelings and unusually tired was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Nausea
Clinical narrative: Nausea; Joint pain; tired; headache; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 29Apr2021 at 10:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included pneumonia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 08:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. On 30Apr2021 at 07:00, the patient experienced nausea, joint pain, was tired and had a headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, joint pain, tired and headache was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Fatigue, Headache, Menstrual disorder, Nasopharyngitis
Clinical narrative: Cold symptoms; Loss of smell; More than usual clots during monthly period; Sore arm; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 22Apr2021 at 17:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to fresh mint leaf. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 31Mar2021 at 18:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient previously received codeine on an unknown date and experienced drug allergy. On 28Apr2021, the patient experienced sore arm, cold symptoms, loss of smell, headache, fatigue, and had more than usual clots during monthly period. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The patient underwent rapid test via nasal swab on 01May2021 and the result was negative. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL and Ibuprofen. The clinical outcome of the events sore arm, cold symptoms, loss of smell, headache, fatigue, and more than usual clots during monthly period were not recovered at the time of report.   No follow-up attempts are possible. No further information is expected.